Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography

Flordeliza S. Villanueva, Thomas Richard Porter, Feng Xie

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Myocardial contrast enhancement following intravenous infusions or injections of perfluorocarbon-containing microbubbles has now been observed consistently in humans. Currently, the major challenge facing us is interpreting accurately what we see. The myocardial contrast patterns we observe have, thus far, been shown to detect myocardial perfusion abnormalities during dipyridamole, adenosine, and dobutamine stress echocardiography. They also have been shown to detect zones of no refiow following coronary revascularization in patients with acute myocardial infarction. These preliminary data will require validation in larger multicenter clinical studies.

Original languageEnglish (US)
Pages (from-to)399-407
Number of pages9
JournalEchocardiography
Volume19
Issue number5
DOIs
StatePublished - Jan 1 2002

Fingerprint

Fluorocarbons
Stress Echocardiography
Microbubbles
Dipyridamole
Intravenous Infusions
Intravenous Injections
Adenosine
Multicenter Studies
Echocardiography
Coronary Artery Disease
Perfusion
Myocardial Infarction
Clinical Studies

Keywords

  • Harmonics
  • Intermittent imaging
  • Microbubbles
  • Perfluorocarbons
  • Ultrasound

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography. / Villanueva, Flordeliza S.; Porter, Thomas Richard; Xie, Feng.

In: Echocardiography, Vol. 19, No. 5, 01.01.2002, p. 399-407.

Research output: Contribution to journalArticle

@article{cbd4da99744a44ed88fa35df845e1569,
title = "Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography",
abstract = "Myocardial contrast enhancement following intravenous infusions or injections of perfluorocarbon-containing microbubbles has now been observed consistently in humans. Currently, the major challenge facing us is interpreting accurately what we see. The myocardial contrast patterns we observe have, thus far, been shown to detect myocardial perfusion abnormalities during dipyridamole, adenosine, and dobutamine stress echocardiography. They also have been shown to detect zones of no refiow following coronary revascularization in patients with acute myocardial infarction. These preliminary data will require validation in larger multicenter clinical studies.",
keywords = "Harmonics, Intermittent imaging, Microbubbles, Perfluorocarbons, Ultrasound",
author = "Villanueva, {Flordeliza S.} and Porter, {Thomas Richard} and Feng Xie",
year = "2002",
month = "1",
day = "1",
doi = "10.1046/j.1540-8175.2002.00399.x",
language = "English (US)",
volume = "19",
pages = "399--407",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography

AU - Villanueva, Flordeliza S.

AU - Porter, Thomas Richard

AU - Xie, Feng

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Myocardial contrast enhancement following intravenous infusions or injections of perfluorocarbon-containing microbubbles has now been observed consistently in humans. Currently, the major challenge facing us is interpreting accurately what we see. The myocardial contrast patterns we observe have, thus far, been shown to detect myocardial perfusion abnormalities during dipyridamole, adenosine, and dobutamine stress echocardiography. They also have been shown to detect zones of no refiow following coronary revascularization in patients with acute myocardial infarction. These preliminary data will require validation in larger multicenter clinical studies.

AB - Myocardial contrast enhancement following intravenous infusions or injections of perfluorocarbon-containing microbubbles has now been observed consistently in humans. Currently, the major challenge facing us is interpreting accurately what we see. The myocardial contrast patterns we observe have, thus far, been shown to detect myocardial perfusion abnormalities during dipyridamole, adenosine, and dobutamine stress echocardiography. They also have been shown to detect zones of no refiow following coronary revascularization in patients with acute myocardial infarction. These preliminary data will require validation in larger multicenter clinical studies.

KW - Harmonics

KW - Intermittent imaging

KW - Microbubbles

KW - Perfluorocarbons

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=0036637620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036637620&partnerID=8YFLogxK

U2 - 10.1046/j.1540-8175.2002.00399.x

DO - 10.1046/j.1540-8175.2002.00399.x

M3 - Article

VL - 19

SP - 399

EP - 407

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 5

ER -